Protein tyrosine phosphatases (PTPs) are drug targets for a wide range of diseases, ranging from vascular anomalies and cancer (DUSP5) to diabetes (PTP1B) [4–16]. This evidence concerns the gene PTPN1 and diabetes mellitus.